Loxo Oncology
Financial ratios & Valuation

Historical Multiples (2014 – 2017)

2014 2015 2016 2017 TTM Median
Valuation Ratios
Price/Earnings ratio
N/AN/AN/AN/AN/AN/A
Price/Sales ratio
N/AN/AN/AN/AN/AN/A
Price/Book Value ratio
N/AN/AN/AN/AN/AN/A
Price/Cash Flow ratio
N/AN/AN/AN/AN/AN/A
Price/Free Cash Flow ratio
N/AN/AN/AN/AN/AN/A
Price/Earnings Growth ratio
N/AN/AN/AN/AN/AN/A
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%100%
Operating Profit Margin
-114944.44%-18128.14%-9381.79%-4329.43%-58.31%-18128.14%
Pretax Profit Margin
115000%-18128.14%-9282.05%-4229.43%-50.38%-18128.14%
Net Profit Margin
-114844.44%-18028.14%-9281.79%-4229.43%-50.38%-18028.14%
Effective Tax Rate
199.95%N/A-1.07%-2.36%N/AN/A
Return on Assets
-18.06%-22.78%-49.82%-19.00%-9.55%-22.78%
Return On Equity
-18.34%-23.20%-55.61%-39.36%-16.42%-23.20%
Return on Capital Employed
-18.11%-22.96%-50.72%-27.12%-15.01%-22.96%
Liquidity Ratios
Current Ratio
450.94424.50133.643.523.61133.64
Quick Ratio
450.94424.50133.643.523.57133.64
Cash ratio
183.80184.7628.620.640.7828.62
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.010.010.090.020.420.01
Debt Equity Ratio
0.010.010.100.050.730.01
Long-term Debt to Capitalization
0.010.010.090.050.100.01
Total Debt to Capitalization
0.010.010.090.050.280.01
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-11.43-11.24-3.644.781.56-11.24
Company Equity Multiplier
1.011.011.112.071.731.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-983.05-151.66-65.7930.611.87-151.66
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.000.990.981.00
Cash Flow Coverage Ratio
-11.43-11.24-3.644.781.56-11.24
Short Term Coverage Ratio
N/A-301.82N/A31.69K2.20-301.82
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A